Issue 12 - The Cancer Letter

The COVID-19 pandemic gives us the urgency—and one more chance—to address health disparities

This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.

ASCO's Response to COVID-19

COVID-19 and Cancer Consortium

Sifting through fatality data and projections on COVID-19: People with cancer, other comorbidities face highest risk

One cancer patient's struggle to get a COVID-19 test

Nelson: How Hopkins is managing COVID-19 pandemic

Curigliano: “I don't want to see more people dying”

What community cancer centers need to know about COVID-19

In Brief

NCCN releases recommendations for standardizing quality measurements in oncology

UCLA awarded $2.7 million to study AI role in improving cancer diagnosis

FDA requires new health warnings on cigarette packages, ads

Clinical Roundup

Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers

Study suggests link between BMI, nutritional markers, and chemotherapy toxicity in older adults with tumors

Study: Melanoma is killing fewest Americans

Drugs & Targets

China accepts sNDA for Zejula in ovarian cancer indication

The U.K. removes Keytruda from Cancer Drug Fund in bladder cancer indication

FDA approves Herzuma, equivalent of Herceptin, in indications

Deaya, Pfizer collaborate on clinical trials

Recent Issues

Trending Stories

Renew today!

Subscriber content

Login